Position in CABR
as of Mar 31, 2026
· filed May 12, 2026
Position Value
$40,660
+$11,106 QoQ
Shares Held
35,668
+3.5% QoQ
Ownership
0.392%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#3
of 6 holders
Holding Since
Dec 2025
2 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CABR Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026JANE STREET GROUP, LLC holds $181,243,153 across 41 Drug Manufacturers - Specialty & Generic names. CABR ranks #41 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TEVA |
Teva Pharmaceutical Industries Ltd
|
1,464,638 | $44,114,896 | |
| 2 | LQDA |
Liquidia Corp
|
795,884 | $30,036,661 | |
| 3 | VTRS |
Viatris Inc
|
2,192,665 | $29,622,903 | |
| 4 | HLN |
Haleon plc
|
2,291,768 | $22,940,596 | |
| 5 | BCRX |
Biocryst Pharmaceuticals Inc
|
622,607 | $5,927,217 | |
| 6 | HIMS |
Hims & Hers Health, Inc.
|
240,170 | $4,985,929 | |
| 7 | AQST |
Aquestive Therapeutics, Inc.
|
1,030,050 | $4,274,707 | |
| 8 | XERS |
Xeris Biopharma Holdings, Inc.
|
725,616 | $4,208,572 |
All Filings in CABR
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $40,660 | 35,668 | Shares | Defined | 2026-05-12 | |
| 2025-12-31 | $29,554 | 34,446 | Shares | Defined | 2026-02-12 | |
| No filing history on record for this holder in this stock. | ||||||